US Neurosurgical Inc., FastFunds Financial Corp., Alcatel Lucent Soci and Amarin Corporation Plc from on April 9th, 2014


Miami, FL -- (SBWIRE) -- 04/09/2014 -- a leading online financial newsletter source, Reports on the following Companies: US Neurosurgical Inc. (OTCMKTS:USNU), FastFunds Financial Corp. (OTCMKTS:FFFC), Alcatel Lucent Soci (NYSE:ALU) and Amarin Corporation plc (NASDAQ:AMRN).

Every day we scan the markets for the hottest stocks with the best potential for huge gains. Our vast network is second to none when it comes to delivering fast moving stocks and more importantly getting you out in front of them.

Join Us Here:

US Neurosurgical Inc. (OTCMKTS:USNU), U.S. NeuroSurgical, Inc. owns and operates stereotactic radiosurgery centers that utilize the gamma knife technology. The gamma knife is a stereotactic radiosurgical device used to treat brain tumors and other malformations of the brain without invasive surgery. It owns and operates a gamma knife center on the premises of New York University Medical Center in New York, New York; and Southern California Regional Gamma Knife Center at the San Antonio Community Hospital in Upland, California. The company was founded in 1993 and is based in Rockville, Maryland.

Get a Free Technical Analysis on US Neurosurgical Inc. (OTCMKTS:USNU):

FastFunds Financial Corp. (OTCMKTS:FFFC), FastFunds Financial Corp., through its subsidiary, Advanced Technology Development, Inc., holds a license related to a provisional patent titled, METHOD OF SEPARATING CARBON DIOXIDE. The companys patent is related to methods of decomposing a gaseous medium, primarily relating to methods of utilizing radio frequency energy to separate the elemental components of gases, such as carbon dioxide. It intends to commence research and development with a goal of potential commercialization. The company was founded in 1992 and is based in West Palm Beach, Florida.

Get a Free Technical Analysis on FastFunds Financial Corp. (OTCMKTS:FFFC):

Alcatel Lucent Soci (NYSE:ALU), Alcatel Lucent Société Anonyme provides Internet protocol (IP) and cloud networking, and ultra-broadband fixed and wireless access to service providers and their customers, enterprises, and institutions worldwide. It operates through three segments: Core Networking, Access, and Other. The Core Networking segment provides service routers and switches designed to support IP-based applications and services; and terrestrial optical products, which enable carriers to manage voice, data, and video traffic patterns based on various applications or platforms. It also develops, manufactures, installs, and maintains undersea telecommunications cable networks; and provides microwave radio products, as well as offers network build and implementation IP, platforms, and platforms professional services. The Access segment offers wireless products and services that enable mobile network operators to offer mobile data capacity; cable, antenna, tower systems, and their related electronic components; and fixed access products, which allow service providers to offer high speed broadband connectivity over copper and fiber connections. It also provides wireless and fixed network build and implementation, multivendor maintenance, licensing, and managed services. The Other segment offers communications and network solutions for businesses of various sizes to deliver collaborative conversations. This segment also serves communications needs of government agencies through building converged voice and network infrastructure for various governmental authorities. Alcatel Lucent Société Anonyme serves various industries, including power utilities, oil and gas, defense, public safety, state and local government, highways, and railways. The company was formerly known as Alcatel, S.A. and changed its name to Alcatel Lucent Société Anonyme in November 2006. The company was founded in 1898 and is headquartered in Paris, France.

Get a Free Technical Analysis on Alcatel Lucent Soci (NYSE:ALU):

Amarin Corporation plc (NASDAQ:AMRN), Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases. Its product development program areas include lipid science and therapeutic benefits of polyunsaturated fatty acids. The company lead product comprises Vascepa, a prescription-only omega-3 fatty acid comprising icosapent ethyl as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It also engages in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is headquartered in Dublin, Ireland.

Get a Free Technical Analysis on Amarin Corporation plc (NASDAQ:AMRN),:

Disclosure: We are not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit for complete risks and disclosures.